177 related articles for article (PubMed ID: 9366523)
61. Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein.
Diakos C; Xiao Y; Zheng S; Kager L; Dworzak M; Wiemels JL
PLoS One; 2014; 9(2):e87602. PubMed ID: 24503810
[TBL] [Abstract][Full Text] [Related]
62. A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1.
McWhirter JR; Goulding M; Weiner JA; Chun J; Murre C
Development; 1997 Sep; 124(17):3221-32. PubMed ID: 9310317
[TBL] [Abstract][Full Text] [Related]
63. Meis proteins are major in vivo DNA binding partners for wild-type but not chimeric Pbx proteins.
Chang CP; Jacobs Y; Nakamura T; Jenkins NA; Copeland NG; Cleary ML
Mol Cell Biol; 1997 Oct; 17(10):5679-87. PubMed ID: 9315626
[TBL] [Abstract][Full Text] [Related]
64. Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.
Sera Y; Yamasaki N; Oda H; Nagamachi A; Wolff L; Inukai T; Inaba T; Honda H
Cancer Sci; 2016 Jul; 107(7):890-8. PubMed ID: 27088431
[TBL] [Abstract][Full Text] [Related]
65. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts.
Fu X; Kamps MP
Mol Cell Biol; 1997 Mar; 17(3):1503-12. PubMed ID: 9032278
[TBL] [Abstract][Full Text] [Related]
66. Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia.
Privitera E; Kamps MP; Hayashi Y; Inaba T; Shapiro LH; Raimondi SC; Behm F; Hendershot L; Carroll AJ; Baltimore D
Blood; 1992 Apr; 79(7):1781-8. PubMed ID: 1348433
[TBL] [Abstract][Full Text] [Related]
67. Protein kinase A-dependent transactivation by the E2A-Pbx1 fusion protein.
Ogo A; Waterman MR; Kamps MP; Kagawa N
J Biol Chem; 1995 Oct; 270(43):25340-3. PubMed ID: 7592695
[TBL] [Abstract][Full Text] [Related]
68. E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia.
Duque-Afonso J; Lin CH; Han K; Wei MC; Feng J; Kurzer JH; Schneidawind C; Wong SH; Bassik MC; Cleary ML
Cancer Res; 2016 Dec; 76(23):6937-6949. PubMed ID: 27758892
[TBL] [Abstract][Full Text] [Related]
69. Transcriptional profiling during the early differentiation of granulocyte and monocyte progenitors controlled by conditional versions of the E2a-Pbx1 oncoprotein.
Sykes DB; Scheele J; Pasillas M; Kamps MP
Leuk Lymphoma; 2003 Jul; 44(7):1187-99. PubMed ID: 12916872
[TBL] [Abstract][Full Text] [Related]
70. Rational design of an immunoconjugate for selective knock-down of leukemia-specific E2A-PBX1 fusion gene expression in human Pre-B leukemia.
Uckun FM; Qazi S; Dibirdik I; Myers DE
Integr Biol (Camb); 2013 Jan; 5(1):122-32. PubMed ID: 22990208
[TBL] [Abstract][Full Text] [Related]
71. The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1.
Scheele JS; Kolanczyk M; Gantert M; Zemojtel T; Dorn A; Sykes DB; Möbest DC; Kamps MP; Räpple D
Leuk Lymphoma; 2009 May; 50(5):816-28. PubMed ID: 19399691
[TBL] [Abstract][Full Text] [Related]
72. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
Hirose K; Inukai T; Kikuchi J; Furukawa Y; Ikawa T; Kawamoto H; Oram SH; Göttgens B; Kiyokawa N; Miyagawa Y; Okita H; Akahane K; Zhang X; Kuroda I; Honna H; Kagami K; Goi K; Kurosawa H; Look AT; Matsui H; Inaba T; Sugita K
Blood; 2010 Aug; 116(6):962-70. PubMed ID: 20519628
[TBL] [Abstract][Full Text] [Related]
73. E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells.
Bayly R; Chuen L; Currie RA; Hyndman BD; Casselman R; Blobel GA; LeBrun DP
J Biol Chem; 2004 Dec; 279(53):55362-71. PubMed ID: 15507449
[TBL] [Abstract][Full Text] [Related]
74. A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A-PBX1 transgenic mice.
Feldman BJ; Hampton T; Cleary ML
Blood; 2000 Sep; 96(5):1906-13. PubMed ID: 10961893
[TBL] [Abstract][Full Text] [Related]
75. Retrovirus-Mediated Expression of E2A-PBX1 Blocks Lymphoid Fate but Permits Retention of Myeloid Potential in Early Hematopoietic Progenitors.
Woodcroft MW; Nanan K; Thompson P; Tyryshkin K; Smith SP; Slany RK; LeBrun DP
PLoS One; 2015; 10(6):e0130495. PubMed ID: 26098938
[TBL] [Abstract][Full Text] [Related]
76. Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1.
Smith KS; Chanda SK; Lingbeek M; Ross DT; Botstein D; van Lohuizen M; Cleary ML
Mol Cell; 2003 Aug; 12(2):393-400. PubMed ID: 14536079
[TBL] [Abstract][Full Text] [Related]
77. Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1.
Denis CM; Chitayat S; Plevin MJ; Wang F; Thompson P; Liu S; Spencer HL; Ikura M; LeBrun DP; Smith SP
Blood; 2012 Nov; 120(19):3968-77. PubMed ID: 22972988
[TBL] [Abstract][Full Text] [Related]
78. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells.
Altura RA; Inukai T; Ashmun RA; Zambetti GP; Roussel MF; Look AT
Blood; 1998 Aug; 92(4):1397-405. PubMed ID: 9694729
[TBL] [Abstract][Full Text] [Related]
79. Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation.
Lu Q; Wright DD; Kamps MP
Mol Cell Biol; 1994 Jun; 14(6):3938-48. PubMed ID: 7910944
[TBL] [Abstract][Full Text] [Related]
80. Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.
Duque-Afonso J; Feng J; Scherer F; Lin CH; Wong SH; Wang Z; Iwasaki M; Cleary ML
J Clin Invest; 2015 Sep; 125(9):3667-80. PubMed ID: 26301816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
